Ferro-Alloy Resources Balasausqandiq study confirms world-class cost advantage (LON:FAR) 20 October 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Verge Technologies: Removing the Boundaries of Cloud Dependence with Intelligent, Self-Healing Data Mobility (Video)
Ferro-Alloy Resources Unveils Compelling Potential Following Robust Feasibility Study (LON:FAR) – Panmure Liberum 17 October 2025
AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer 16 December 2025
Kingfisher PLC (KGF.L) Stock Analysis: Navigating a Challenging Landscape with a 3.84% Dividend Yield 12 January 2026
Vodafone Group (VOD.L) Investor Outlook: Navigating a Complex Landscape with a 3.88% Dividend Yield 12 January 2026
Weir Group PLC (WEIR.L) Stock Analysis: Exploring a 4.62% Potential Upside Amid Strong Buy Ratings 12 January 2026
Vistry Group PLC (VTY.L): Navigating Residential Construction with Insights on Analyst Ratings and Market Performance 12 January 2026
GSK PLC (GSK.L) Stock Analysis: Navigating Dividend Yield and Revenue Growth in the Healthcare Sector 12 January 2026
Ferro-Alloy Resources Balasausqandiq study confirms world-class cost advantage (LON:FAR) 20 October 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Verge Technologies: Removing the Boundaries of Cloud Dependence with Intelligent, Self-Healing Data Mobility (Video)
Ferro-Alloy Resources Unveils Compelling Potential Following Robust Feasibility Study (LON:FAR) – Panmure Liberum 17 October 2025
AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer 16 December 2025
Kingfisher PLC (KGF.L) Stock Analysis: Navigating a Challenging Landscape with a 3.84% Dividend Yield 12 January 2026
Vodafone Group (VOD.L) Investor Outlook: Navigating a Complex Landscape with a 3.88% Dividend Yield 12 January 2026
Weir Group PLC (WEIR.L) Stock Analysis: Exploring a 4.62% Potential Upside Amid Strong Buy Ratings 12 January 2026
Vistry Group PLC (VTY.L): Navigating Residential Construction with Insights on Analyst Ratings and Market Performance 12 January 2026
GSK PLC (GSK.L) Stock Analysis: Navigating Dividend Yield and Revenue Growth in the Healthcare Sector 12 January 2026
Niagen Bioscience, Inc. (NAGE) Stock Analysis: A Promising 117% Upside Potential Ignites Investor Interest 3 October 2025
Evolus, Inc. (EOLS) Stock Analysis: Unveiling a Potential 201% Upside with Analyst Confidence 3 October 2025
Immunome, Inc. (IMNM) Investor Outlook: Strong Buy Ratings Signal Potential 109% Upside 3 October 2025
Replimune Group, Inc. (REPL): Investor Outlook on Emerging Biotech with Oncolytic Immunotherapy Potential 3 October 2025
Personalis, Inc. (PSNL) Stock Analysis: Navigating Growth Challenges Amidst Promising Advances in Cancer Genomics 3 October 2025
CureVac N.V. (CVAC) Stock Analysis: Navigating a Biotech Pioneer with a Strong Return on Equity 3 October 2025
Opthea Limited (OPT) Stock Analysis: Navigating the Biotech Waters with Potential Downside 3 October 2025
Pharvaris N.V. (PHVS) Stock Analysis: Unpacking a Potential 46% Upside Amidst Biotech Innovations 3 October 2025
Auna SA (AUNA) Stock Analysis: Exploring a Potential 79% Upside in the Healthcare Sector 3 October 2025
AnaptysBio, Inc. (ANAB) Stock Analysis: Biotechnology Innovator with a 65% Potential Upside 3 October 2025
Amylyx Pharmaceuticals (AMLX) Investor Outlook: Evaluating the 13.81% Upside Potential 3 October 2025
iRadimed Corporation (IRMD) Stock Analysis: A Healthcare Innovator with a 5.51% Upside Potential 3 October 2025
Ginkgo Bioworks (DNA) Stock Analysis: Navigating Challenges with Biotechnology Innovations 3 October 2025
Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating Market Dynamics with a 38.60% Revenue Growth 3 October 2025
Zevra Therapeutics, Inc. (ZVRA) Stock Analysis: Unlocking a 149% Potential Upside in Rare Disease Treatment 3 October 2025
Community Health Systems, Inc. (CYH) Stock Analysis: Navigating a 16% Potential Upside 3 October 2025
Fulgent Genetics, Inc. (FLGT) Stock Analysis: Unveiling a Potential 10.63% Upside in the Healthcare Sector 3 October 2025
Cizzle Biotechnology New NHS-Aligned Partnership Moves Lung Cancer Test Closer to UK Clinics (Video) 6 November 2025
Great Western Mining Corporation Copper-Tungsten Discovery Unveils Major Nevada Upside (Video) 30 October 2025
Verge Technologies: Removing the Boundaries of Cloud Dependence with Intelligent, Self-Healing Data Mobility (Video) 28 October 2025
Gattaca: AI-Driven Growth, Strategic Focus and Why FY26 Could Be a Breakout Year (Video) 24 October 2025
Ilika plc Goliath Pilot Line Now Fully Operational, Paving the Road to Licensing Deals (Video) 22 October 2025
Berkeley Group posts £254 million profit and maintains strong cash position in interim results 10 December 2025
Harbour Energy to acquire Waldorf subsidiaries in $170m deal, boosting UK production 12 December 2025
TwentyFour Income Fund reports positive month as ABS and CLO issuance hits post-crisis highs 12 December 2025
Prediction markets move into the mainstream as trading surges | Ruffer Investment Company 12 December 2025
Ferro-Alloy Resources Balasausqandiq study confirms world-class cost advantage (LON:FAR) 20 October 2025
Ferro-Alloy Resources Unveils Compelling Potential Following Robust Feasibility Study (LON:FAR) – Panmure Liberum 17 October 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Kingfisher PLC (KGF.L) Stock Analysis: Navigating a Challenging Landscape with a 3.84% Dividend Yield 12 January 2026
Vodafone Group (VOD.L) Investor Outlook: Navigating a Complex Landscape with a 3.88% Dividend Yield 12 January 2026
Weir Group PLC (WEIR.L) Stock Analysis: Exploring a 4.62% Potential Upside Amid Strong Buy Ratings 12 January 2026
Vistry Group PLC (VTY.L): Navigating Residential Construction with Insights on Analyst Ratings and Market Performance 12 January 2026
GSK PLC (GSK.L) Stock Analysis: Navigating Dividend Yield and Revenue Growth in the Healthcare Sector 12 January 2026
